CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production

By Li Xiaoli  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1607-1618

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

By Zhang Yuyi   Lin Ang   Zhang Cai   Tian Zhigang   Zhang Jian  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 357-367

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of human adenocarcinoma with CpG-ODN in a mouse model

By          

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1061-1063

Spandidos Publications

Access to resources Recommend Favorite

Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces longlasting and balanced immune responses

By                                

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 915-924

Spandidos Publications

Access to resources Recommend Favorite

Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells

By          

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 1121-1130

Spandidos Publications

Access to resources Recommend Favorite